APO Research
Talk to an analyst

APO RESEARCH · REPORT

Serological Pipettes

Serological pipette is a type of graduated pipette in which the calibration marks extend all the way to the tip. It is usually made from transparent PS (Polystyrene).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Serological pipette is a type of graduated pipette in which the calibration marks extend all the way to the tip. It is usually made from transparent PS (Polystyrene).

Selected research

Market Outlook & Growth Opportunities

Global Serological Pipettes Market Outlook and Growth Opportunities 2026

22 December 2025206 pages

Choose your research edition.

Industry ResearchSerological Pipettes Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Serological Pipettes Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Serological Pipettes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Serological Pipettes Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Serological Pipettes Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Serological pipette is a type of graduated pipette in which the calibration marks extend all the way to the tip. It is usually made from transparent PS (Polystyrene).

Global Serological Pipettes main players are Thermo Fisher Scientific, Corning, VWR, Sarstedt, etc. Global top four manufacturers hold a share over 30%. China is the largest market, with a share nearly 35%.

This report provides an overview of the global Serological Pipettes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Serological Pipettes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Serological Pipettes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Serological Pipettes market size, projected growth trends, production technologies, key applications, and end-use industries.

Serological Pipettes Segment by Company

Thermo Fisher Scientific

Corning

VWR

Sarstedt

Merck

Eppendorf

Argos Technologies

CAPP

Camlab

HiMedia Laboratories

TPP

Greiner Bio-One

Biofil

NEST

Sorfa

CITOTEST

Serological Pipettes Segment by Type

1-2 ml

5 ml

10 ml

25 ml

Serological Pipettes Segment by Application

Tissue Culture

Bacterial Culture

Testing Lab

Others

Serological Pipettes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Serological Pipettes status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Serological Pipettes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Serological Pipettes significant trends, drivers, influence factors in global and regions.

6. To analyze Serological Pipettes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serological Pipettes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Serological Pipettes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serological Pipettes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Serological Pipettes market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Serological Pipettes industry.

Chapter 3: Detailed analysis of Serological Pipettes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Serological Pipettes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Serological Pipettes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Serological Pipettes Industry Trends Table 2. Serological Pipettes Industry Drivers Table 3. Serological Pipettes Industry Opportunities and Challenges Table 4. Serological Pipettes Industry Restraints Table 5. Global Serological Pipettes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Serological Pipettes Revenue Share by Company (2021-2026) Table 7. Global Serological Pipettes Sales Volume by Company (M Pcs) & (2021-2026) Table 8. Global Serological Pipettes Sales Volume Share by Company (2021-2026) Table 9. Global Serological Pipettes Average Price (USD/K Pcs) of Company (2021-2026) Table 10. Global Serological Pipettes Company Ranking, (2024-2026) & (USD Million) Table 11. Global Serological Pipettes Key Company Manufacturing Base & Headquarters Table 12. Global Serological Pipettes Company, Product Type & Application Table 13. Global Serological Pipettes Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Serological Pipettes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1-2 ml Table 18. Significant Companies of 5 ml Table 19. Significant Companies of 10 ml Table 20. Significant Companies of 25 ml Table 21. Global Serological Pipettes Sales Volume by Type 2021 VS 2025 VS 2032 (M Pcs) Table 22. Global Serological Pipettes Sales Volume by Type (2021-2026) & (M Pcs) Table 23. Global Serological Pipettes Sales Volume by Type (2027-2032) & (M Pcs) Table 24. Global Serological Pipettes Sales Volume Share by Type (2021-2026) Table 25. Global Serological Pipettes Sales Volume Share by Type (2027-2032) Table 26. Global Serological Pipettes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Serological Pipettes Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Serological Pipettes Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Serological Pipettes Sales Value Share by Type (2021-2026) Table 30. Global Serological Pipettes Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Tissue Culture Table 32. Significant Companies of Bacterial Culture Table 33. Significant Companies of Testing Lab Table 34. Significant Companies of Others Table 35. Global Serological Pipettes Sales Volume by Application 2021 VS 2025 VS 2032 (M Pcs) Table 36. Global Serological Pipettes Sales Volume by Application (2021-2026) & (M Pcs) Table 37. Global Serological Pipettes Sales Volume by Application (2027-2032) & (M Pcs) Table 38. Global Serological Pipettes Sales Volume Share by Application (2021-2026) Table 39. Global Serological Pipettes Sales Volume Share by Application (2027-2032) Table 40. Global Serological Pipettes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Serological Pipettes Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Serological Pipettes Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Serological Pipettes Sales Value Share by Application (2021-2026) Table 44. Global Serological Pipettes Sales Value Share by Application (2027-2032) Table 45. Global Serological Pipettes Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 46. Global Serological Pipettes Sales by Region (2021-2026) & (M Pcs) Table 47. Global Serological Pipettes Sales Market Share by Region (2021-2026) Table 48. Global Serological Pipettes Sales by Region (2027-2032) & (M Pcs) Table 49. Global Serological Pipettes Sales Market Share by Region (2027-2032) Table 50. Global Serological Pipettes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Serological Pipettes Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Serological Pipettes Sales Value Share by Region (2021-2026) Table 53. Global Serological Pipettes Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Serological Pipettes Sales Value Share by Region (2027-2032) Table 55. Global Serological Pipettes Market Average Price (USD/K Pcs) by Region (2021-2026) Table 56. Global Serological Pipettes Market Average Price (USD/K Pcs) by Region (2027-2032) Table 57. Global Serological Pipettes Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 58. Global Serological Pipettes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Serological Pipettes Sales by Country (2021-2026) & (M Pcs) Table 60. Global Serological Pipettes Sales Market Share by Country (2021-2026) Table 61. Global Serological Pipettes Sales by Country (2027-2032) & (M Pcs) Table 62. Global Serological Pipettes Sales Market Share by Country (2027-2032) Table 63. Global Serological Pipettes Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Serological Pipettes Sales Value Market Share by Country (2021-2026) Table 65. Global Serological Pipettes Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Serological Pipettes Sales Value Market Share by Country (2027-2032) Table 67. Thermo Fisher Scientific Company Information Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 70. Thermo Fisher Scientific Serological Pipettes Product Portfolio Table 71. Thermo Fisher Scientific Recent Development Table 72. Corning Company Information Table 73. Corning Business Overview Table 74. Corning Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 75. Corning Serological Pipettes Product Portfolio Table 76. Corning Recent Development Table 77. VWR Company Information Table 78. VWR Business Overview Table 79. VWR Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 80. VWR Serological Pipettes Product Portfolio Table 81. VWR Recent Development Table 82. Sarstedt Company Information Table 83. Sarstedt Business Overview Table 84. Sarstedt Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 85. Sarstedt Serological Pipettes Product Portfolio Table 86. Sarstedt Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 90. Merck Serological Pipettes Product Portfolio Table 91. Merck Recent Development Table 92. Eppendorf Company Information Table 93. Eppendorf Business Overview Table 94. Eppendorf Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 95. Eppendorf Serological Pipettes Product Portfolio Table 96. Eppendorf Recent Development Table 97. Argos Technologies Company Information Table 98. Argos Technologies Business Overview Table 99. Argos Technologies Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 100. Argos Technologies Serological Pipettes Product Portfolio Table 101. Argos Technologies Recent Development Table 102. CAPP Company Information Table 103. CAPP Business Overview Table 104. CAPP Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 105. CAPP Serological Pipettes Product Portfolio Table 106. CAPP Recent Development Table 107. Camlab Company Information Table 108. Camlab Business Overview Table 109. Camlab Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 110. Camlab Serological Pipettes Product Portfolio Table 111. Camlab Recent Development Table 112. HiMedia Laboratories Company Information Table 113. HiMedia Laboratories Business Overview Table 114. HiMedia Laboratories Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 115. HiMedia Laboratories Serological Pipettes Product Portfolio Table 116. HiMedia Laboratories Recent Development Table 117. TPP Company Information Table 118. TPP Business Overview Table 119. TPP Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 120. TPP Serological Pipettes Product Portfolio Table 121. TPP Recent Development Table 122. Greiner Bio-One Company Information Table 123. Greiner Bio-One Business Overview Table 124. Greiner Bio-One Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 125. Greiner Bio-One Serological Pipettes Product Portfolio Table 126. Greiner Bio-One Recent Development Table 127. Biofil Company Information Table 128. Biofil Business Overview Table 129. Biofil Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 130. Biofil Serological Pipettes Product Portfolio Table 131. Biofil Recent Development Table 132. NEST Company Information Table 133. NEST Business Overview Table 134. NEST Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 135. NEST Serological Pipettes Product Portfolio Table 136. NEST Recent Development Table 137. Sorfa Company Information Table 138. Sorfa Business Overview Table 139. Sorfa Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 140. Sorfa Serological Pipettes Product Portfolio Table 141. Sorfa Recent Development Table 142. CITOTEST Company Information Table 143. CITOTEST Business Overview Table 144. CITOTEST Serological Pipettes Sales (M Pcs), Value (US$ Million), Price (USD/K Pcs) and Gross Margin (2021-2026) Table 145. CITOTEST Serological Pipettes Product Portfolio Table 146. CITOTEST Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Serological Pipettes Distributors List Table 150. Serological Pipettes Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Serological Pipettes Product Image Figure 2. Global Serological Pipettes Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Serological Pipettes Sales Value (2021-2032) & (US$ Million) Figure 4. Global Serological Pipettes Sales (2021-2032) & (M Pcs) Figure 5. Global Serological Pipettes Sales Average Price (USD/K Pcs) & (2021-2032) Figure 6. Global Serological Pipettes Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1-2 ml Image Figure 10. 5 ml Image Figure 11. 10 ml Image Figure 12. 25 ml Image Figure 13. Global Serological Pipettes Sales Volume by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 14. Global Serological Pipettes Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Serological Pipettes Sales Volume Share by Type (2021-2032) Figure 16. Global Serological Pipettes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Serological Pipettes Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Serological Pipettes Sales Value Share by Type (2021-2032) Figure 19. Tissue Culture Image Figure 20. Bacterial Culture Image Figure 21. Testing Lab Image Figure 22. Others Image Figure 23. Global Serological Pipettes Sales Volume by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 24. Global Serological Pipettes Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Serological Pipettes Sales Volume Share by Application (2021-2032) Figure 26. Global Serological Pipettes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Serological Pipettes Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Serological Pipettes Sales Value Share by Application (2021-2032) Figure 29. Global Serological Pipettes Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 30. Global Serological Pipettes Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Serological Pipettes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Serological Pipettes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Serological Pipettes Sales Value (2021-2032) & (US$ Million) Figure 34. North America Serological Pipettes Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Serological Pipettes Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Serological Pipettes Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Serological Pipettes Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Serological Pipettes Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Serological Pipettes Sales Value (2021-2032) & (US$ Million) Figure 40. South America Serological Pipettes Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Serological Pipettes Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Serological Pipettes Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Serological Pipettes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Serological Pipettes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Serological Pipettes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Serological Pipettes Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Serological Pipettes Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 1-2 ml
  • 5 ml
  • 10 ml
  • 25 ml
Applications
  • Tissue Culture
  • Bacterial Culture
  • Testing Lab
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Corning
  • VWR
  • Sarstedt
  • Merck
  • Eppendorf
  • Argos Technologies
  • CAPP
  • Camlab
  • HiMedia Laboratories
  • TPP
  • Greiner Bio-One
  • Biofil
  • NEST
  • Sorfa
  • CITOTEST

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Serological Pipettes Sales Value (2021-2032)
  4. 1.2.2 Global Serological Pipettes Sales Volume (2021-2032)
  5. 1.2.3 Global Serological Pipettes Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Serological Pipettes Market Dynamics
  1. 2.1 Serological Pipettes Industry Trends
  2. 2.2 Serological Pipettes Industry Drivers
  3. 2.3 Serological Pipettes Industry Opportunities and Challenges
  4. 2.4 Serological Pipettes Industry Restraints
3 Serological Pipettes Market by Company
  1. 3.1 Global Serological Pipettes Company Revenue Ranking in 2025
  2. 3.2 Global Serological Pipettes Revenue by Company (2021-2026)
  3. 3.3 Global Serological Pipettes Sales Volume by Company (2021-2026)
  4. 3.4 Global Serological Pipettes Average Price by Company (2021-2026)
  5. 3.5 Global Serological Pipettes Company Ranking (2024-2026)
  6. 3.6 Global Serological Pipettes Company Manufacturing Base and Headquarters
  7. 3.7 Global Serological Pipettes Company Product Type and Application
  8. 3.8 Global Serological Pipettes Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Serological Pipettes Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Serological Pipettes Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Serological Pipettes Market by Type
  1. 4.1 Serological Pipettes Type Introduction
  2. 4.1.1 1-2 ml
  3. 4.1.2 5 ml
  4. 4.1.3 10 ml
  5. 4.1.4 25 ml
  6. 4.2 Global Serological Pipettes Sales Volume by Type
  7. 4.2.1 Global Serological Pipettes Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Serological Pipettes Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Serological Pipettes Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Serological Pipettes Sales Value by Type
  11. 4.3.1 Global Serological Pipettes Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Serological Pipettes Sales Value by Type (2021-2032)
  13. 4.3.3 Global Serological Pipettes Sales Value Share by Type (2021-2032)
5 Serological Pipettes Market by Application
  1. 5.1 Serological Pipettes Application Introduction
  2. 5.1.1 Tissue Culture
  3. 5.1.2 Bacterial Culture
  4. 5.1.3 Testing Lab
  5. 5.1.4 Others
  6. 5.2 Global Serological Pipettes Sales Volume by Application
  7. 5.2.1 Global Serological Pipettes Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Serological Pipettes Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Serological Pipettes Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Serological Pipettes Sales Value by Application
  11. 5.3.1 Global Serological Pipettes Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Serological Pipettes Sales Value by Application (2021-2032)
  13. 5.3.3 Global Serological Pipettes Sales Value Share by Application (2021-2032)
6 Serological Pipettes Regional Sales and Value Analysis
  1. 6.1 Global Serological Pipettes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Serological Pipettes Sales by Region (2021-2032)
  3. 6.2.1 Global Serological Pipettes Sales by Region: 2021-2026
  4. 6.2.2 Global Serological Pipettes Sales by Region (2027-2032)
  5. 6.3 Global Serological Pipettes Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Serological Pipettes Sales Value by Region (2021-2032)
  7. 6.4.1 Global Serological Pipettes Sales Value by Region: 2021-2026
  8. 6.4.2 Global Serological Pipettes Sales Value by Region (2027-2032)
  9. 6.5 Global Serological Pipettes Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Serological Pipettes Sales Value (2021-2032)
  12. 6.6.2 North America Serological Pipettes Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Serological Pipettes Sales Value (2021-2032)
  15. 6.7.2 Europe Serological Pipettes Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Serological Pipettes Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Serological Pipettes Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Serological Pipettes Sales Value (2021-2032)
  21. 6.9.2 South America Serological Pipettes Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Serological Pipettes Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Serological Pipettes Sales Value Share by Country, 2025 VS 2032
7 Serological Pipettes Country-level Sales and Value Analysis
  1. 7.1 Global Serological Pipettes Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Serological Pipettes Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Serological Pipettes Sales by Country (2021-2032)
  4. 7.3.1 Global Serological Pipettes Sales by Country (2021-2026)
  5. 7.3.2 Global Serological Pipettes Sales by Country (2027-2032)
  6. 7.4 Global Serological Pipettes Sales Value by Country (2021-2032)
  7. 7.4.1 Global Serological Pipettes Sales Value by Country (2021-2026)
  8. 7.4.2 Global Serological Pipettes Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Serological Pipettes Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Serological Pipettes Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Serological Pipettes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Serological Pipettes Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Serological Pipettes Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Serological Pipettes Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Serological Pipettes Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Serological Pipettes Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Serological Pipettes Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Serological Pipettes Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Serological Pipettes Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Serological Pipettes Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Serological Pipettes Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Serological Pipettes Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Serological Pipettes Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Serological Pipettes Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Serological Pipettes Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Serological Pipettes Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Serological Pipettes Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Serological Pipettes Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Serological Pipettes Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Serological Pipettes Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Serological Pipettes Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Serological Pipettes Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Serological Pipettes Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Serological Pipettes Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Serological Pipettes Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Serological Pipettes Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Serological Pipettes Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Serological Pipettes Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Serological Pipettes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Serological Pipettes Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Corning
  8. 8.2.1 Corning Company Information
  9. 8.2.2 Corning Business Overview
  10. 8.2.3 Corning Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Corning Serological Pipettes Product Portfolio
  12. 8.2.5 Corning Recent Developments
  13. 8.3 VWR
  14. 8.3.1 VWR Company Information
  15. 8.3.2 VWR Business Overview
  16. 8.3.3 VWR Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 VWR Serological Pipettes Product Portfolio
  18. 8.3.5 VWR Recent Developments
  19. 8.4 Sarstedt
  20. 8.4.1 Sarstedt Company Information
  21. 8.4.2 Sarstedt Business Overview
  22. 8.4.3 Sarstedt Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sarstedt Serological Pipettes Product Portfolio
  24. 8.4.5 Sarstedt Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Serological Pipettes Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eppendorf
  32. 8.6.1 Eppendorf Company Information
  33. 8.6.2 Eppendorf Business Overview
  34. 8.6.3 Eppendorf Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eppendorf Serological Pipettes Product Portfolio
  36. 8.6.5 Eppendorf Recent Developments
  37. 8.7 Argos Technologies
  38. 8.7.1 Argos Technologies Company Information
  39. 8.7.2 Argos Technologies Business Overview
  40. 8.7.3 Argos Technologies Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Argos Technologies Serological Pipettes Product Portfolio
  42. 8.7.5 Argos Technologies Recent Developments
  43. 8.8 CAPP
  44. 8.8.1 CAPP Company Information
  45. 8.8.2 CAPP Business Overview
  46. 8.8.3 CAPP Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CAPP Serological Pipettes Product Portfolio
  48. 8.8.5 CAPP Recent Developments
  49. 8.9 Camlab
  50. 8.9.1 Camlab Company Information
  51. 8.9.2 Camlab Business Overview
  52. 8.9.3 Camlab Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Camlab Serological Pipettes Product Portfolio
  54. 8.9.5 Camlab Recent Developments
  55. 8.10 HiMedia Laboratories
  56. 8.10.1 HiMedia Laboratories Company Information
  57. 8.10.2 HiMedia Laboratories Business Overview
  58. 8.10.3 HiMedia Laboratories Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 HiMedia Laboratories Serological Pipettes Product Portfolio
  60. 8.10.5 HiMedia Laboratories Recent Developments
  61. 8.11 TPP
  62. 8.11.1 TPP Company Information
  63. 8.11.2 TPP Business Overview
  64. 8.11.3 TPP Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 TPP Serological Pipettes Product Portfolio
  66. 8.11.5 TPP Recent Developments
  67. 8.12 Greiner Bio-One
  68. 8.12.1 Greiner Bio-One Company Information
  69. 8.12.2 Greiner Bio-One Business Overview
  70. 8.12.3 Greiner Bio-One Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Greiner Bio-One Serological Pipettes Product Portfolio
  72. 8.12.5 Greiner Bio-One Recent Developments
  73. 8.13 Biofil
  74. 8.13.1 Biofil Company Information
  75. 8.13.2 Biofil Business Overview
  76. 8.13.3 Biofil Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biofil Serological Pipettes Product Portfolio
  78. 8.13.5 Biofil Recent Developments
  79. 8.14 NEST
  80. 8.14.1 NEST Company Information
  81. 8.14.2 NEST Business Overview
  82. 8.14.3 NEST Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 NEST Serological Pipettes Product Portfolio
  84. 8.14.5 NEST Recent Developments
  85. 8.15 Sorfa
  86. 8.15.1 Sorfa Company Information
  87. 8.15.2 Sorfa Business Overview
  88. 8.15.3 Sorfa Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sorfa Serological Pipettes Product Portfolio
  90. 8.15.5 Sorfa Recent Developments
  91. 8.16 CITOTEST
  92. 8.16.1 CITOTEST Company Information
  93. 8.16.2 CITOTEST Business Overview
  94. 8.16.3 CITOTEST Serological Pipettes Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CITOTEST Serological Pipettes Product Portfolio
  96. 8.16.5 CITOTEST Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Serological Pipettes Value Chain Analysis
  2. 9.1.1 Serological Pipettes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Serological Pipettes Sales Mode & Process
  6. 9.2 Serological Pipettes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Serological Pipettes Distributors
  9. 9.2.3 Serological Pipettes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst